The present invention relates to an antiviral antibody against SARS-CoV2 that binds to ACE2 and to the use thereof. The purpose of the present invention is to prepare an antibody that binds to hACE2 and to confirm that the antibody exhibits an antiviral effect against SARS-CoV2 by verifying that each antibody inhibits the entry of SARS-CoV2 virus into a cell, thereby providing a composition comprising the antibody as a pharmaceutical composition for preventing or treating infection caused by SARS-CoV2.
